Skip to main navigation

Athenex

Improving the lives of cancer patients everywhere

About
Oncology Innovation
Operating Platforms
- Commercial
- Internal Supply Chain
Investor Relations
Careers

Quarterly Results

Quarterly Results

Show all

2020

Category
Q3 Earnings	Q3 2020 Athenex, Inc. Earnings Conference Call Athenex, Inc. Reports Third Quarter Ended September 30, 2020 Financial Results and Provides Corporate Update Form 10-Q 845.9 KB
Q2 Earnings	Q2 2020 Athenex, Inc. Earnings Conference Call Athenex, Inc. Reports Second Quarter Ended June 30, 2020 Financial Results and Provides Corporate Update Form 10-Q 909.4 KB
Q1 Earnings	Q1 2020 Athenex, Inc. Earnings Conference Call Athenex, Inc. Reports First Quarter Ended March 31, 2020 Financial Results and Provides Corporate Update Form 10-Q 745.7 KB

2019

Category
Q4 Earnings	Q4 2019 Athenex, Inc. Earnings Conference Call Athenex, Inc. Reports Fourth Quarter and Year Ended December 31, 2019 Financial Results and Provides Corporate Update Form 10-K 1.5 MB
Q3 Earnings	Q3 2019 Athenex, Inc. Earnings Conference Call Athenex, Inc. Announces Third Quarter 2019 Financial Results Form 10-Q 502.4 KB
Q2 Earnings	Q2 2019 Athenex, Inc. Earnings Conference Call Athenex, Inc. Announces Second Quarter 2019 Financial Results, Positive Phase III Results on Oral Paclitaxel plus Encequidar and Increased Product Sales Guidance Form 10-Q 1.3 MB
Q1 Earnings	Q1 2019 Athenex, Inc. Earnings Conference Call Athenex, Inc. Announces First Quarter 2019 Financial Results and Provides Corporate Update Form 10-Q 1.2 MB

2018

Category
Q4 Earnings	Athenex, Inc. Announces Fourth Quarter and Year Ended December 31, 2018 Financial Results and Provides Corporate Update
Q3 Earnings	Athenex, Inc. Announces Third Quarter 2018 Financial Results and Provides Corporate Update Form 10-Q 890.4 KB
Q2 Earnings	Athenex, Inc. Announces Second Quarter 2018 Results and Provides Corporate Update Form 10-Q 705.8 KB
Q1 Earnings	Athenex, Inc. Announces First Quarter 2018 Results Form 10-Q 387.1 KB

2017

Category
Q4 Earnings	Athenex, Inc. Announces Fourth Quarter and Full-Year 2017 Results Form 10-K 3.4 MB
Q3 Earnings	Athenex, Inc. Announces Third Quarter 2017 Results Form 10-Q 1.1 MB

sidebar nav

Overview
Stock Information
News & Events
- Press Releases
- Events & Presentations
Financial Information
Corporate Governance
- Governance Highlights
- Committee Composition
Investor Resources

Print Page
RSS
E-mail Alerts

QUICK LINKS

About Athenex
Our Team
Partnerships
Contact

QUICK LINKS

Pipeline
Orascovery
Src Kinase Inhibition
TCR-T Immunotherapy
Arginine Deprivation Therapy
Clinical Trials

QUICK LINKS

Commercial
Internal Supply Chain

QUICK LINKS

News
Investor Relations
Careers

OTHER ATHENEX SITES

Athenex Oncology

Commercializing our proprietary products

Athenex Pharmaceutical Division
Athenex Pharma Solutions

Specialty pharmaceuticals and 503B business

cGMP API manufacturing and distribution

© 2021 Athenex, Inc. All rights reserved.

Privacy Policy
Terms of Use

Follow us